Table 1 Baseline characteristics and clinical outcomes in acute kidney injury patients.
| Ā | Survivor (nā=ā903) | Non-survivor (nā=ā217) | P-value |
|---|---|---|---|
Characteristics | |||
Ā Age, years | 68 (56ā76) | 69 (60ā77) | 0.17 |
Ā Male sex, n (%) | 571 (63.2) | 148 (68.2) | 0.15 |
Ā Body weight, kg | 61.2 (52.6ā71.5) | 60.0 (51.6ā71.7) | 0.43 |
Comorbidity, n (%) | |||
Ā CKD | 155 (17.2) | 44 (20.3) | 0.28 |
Ā Hypertension | 436 (48.3) | 83 (38.2) | 0.008 |
Ā Diabetes mellitus | 218 (24.1) | 50 (23.0) | 0.73 |
Ā APACHE II score | 23 (17ā30) | 32 (26ā40) | <ā0.001 |
Ā SOFA score | 7 (4ā10) | 11 (8ā14) | <ā0.001 |
AKI etiology, n (%) | |||
Ā Cardiovascular disease | 340 (37.7) | 59 (27.2) | 0.004 |
Ā Sepsis | 199 (22.0) | 77 (35.5) | <ā0.001 |
Ā Major surgery | 106 (11.8) | 19 (8.8) | 0.21 |
Ā Hypovolemia | 75 (8.3) | 12 (5.5) | 0.17 |
Ā Severe acute pancreatitis | 32 (3.5) | 5 (2.3) | 0.36 |
Ā Hepatic failure | 19 (2.1) | 13 (6.0) | 0.002 |
Ā Urinary tract obstruction | 7 (0.8) | 1 (0.5) | 0.62 |
Ā Drug-induced | 4 (0.4) | 2 (0.9) | 0.39 |
Ā Burn | 2 (0.2) | 0 (0.0) | 0.49 |
Ā Other and unknown | 115 (12.8) | 29 (13.4) | 0.81 |
KDIGO AKI, n (%) | |||
Ā Stage 1 | 278 (30.8) | 32 (14.7) | <ā0.001 |
Ā Stage 2 | 310 (34.3) | 51 (23.5) | 0.002 |
Ā Stage 3 | 315 (34.9) | 134 (61.8) | <ā0.001 |
Cumulative fluid balance | |||
Ā 0ā24Ā h | 1248.6 (182.0 to 2831.9) | 1955.0 (702.2 to 4520.5) | <ā0.001 |
Ā 24ā48Ā h | 490.0 (āā473.0 to 1386.5) | 941.3 (āā27.4 to 2098.0) | <ā0.001 |
Ā 48ā72Ā h | 32.0 (āā800.0 to 827.5) | 605.8 (āā462.4 to 1439.0) | <ā0.001 |
Outcome | |||
Ā Ventilator-free days | 24 (20ā28) | 2 (0ā12) | <ā0.001 |